Givaudan Research: Zensera Lemon Balm Supports the Mind During Stress

Why It Matters

The findings demonstrate that a natural, acute‑dose ingredient can boost cognition and mood during real‑world stress, offering a non‑sedating alternative for busy professionals. This could reshape functional‑beverage and supplement portfolios targeting mental‑performance consumers.

Key Takeaways

• 130 participants enrolled; 106 completed the five‑hour protocol
• Zensera 300 mg improved demanding cognitive tasks after five hours
• Placebo group showed lower performance on executive‑function tests
• Calmness and contentedness correlated with better cognitive efficiency
• Effects persisted beyond peak rosmarinic‑acid bioavailability

Pulse Analysis

Lemon balm (Melissa officinalis) has long been marketed for its calming properties, yet robust data on its ability to support mental performance under stress have been scarce. As mental‑health concerns dominate consumer conversations—especially among younger and female demographics—flavor and ingredient companies like Givaudan are investing in science‑backed solutions. By isolating a standardized extract, Zensera, Givaudan aims to meet the growing demand for functional ingredients that enhance focus without inducing sedation, positioning itself at the intersection of wellness and performance.

The randomized, double‑blind study recruited 130 healthy adults who followed a low‑polyphenol diet before testing. Participants received either 300 mg of Zensera or a placebo and were evaluated at baseline, then at 1, 3, and 5 hours post‑dose using mood scales, vital signs, and a demanding cognitive battery. While early time points showed modest changes, the five‑hour assessment revealed a clear advantage for the Zensera group on the most challenging tasks, accompanied by higher self‑reported calmness. Notably, these benefits emerged as rosmarinic‑acid concentrations waned, implying that additional phytochemicals in the extract may drive sustained cognitive support.

For product developers, the trial offers a compelling proof point: a single acute dose of a natural extract can enhance both mood and executive function during prolonged stress. This aligns with the trend toward “smart” beverages, nootropics, and stress‑relief supplements that promise immediate, measurable outcomes. However, the study’s lack of biochemical markers and its short‑term scope highlight the need for longer‑term investigations. If future research confirms these effects, Zensera could become a cornerstone ingredient for brands seeking to differentiate in the crowded mental‑performance market.